OPTIKA INC
3, 2000-03-06
PREPACKAGED SOFTWARE
Previous: THERMO OPPORTUNITY FUND INC, DEFS14A, 2000-03-06
Next: OPTIKA INC, 3, 2000-03-06





                                                  ------------------------------
                                                           OMB APPROVAL
                                                  ------------------------------
                                                  OMB Number           3235-0104
                                                  Expires:     December 31, 2001
                                                  Estimated average burden
                                                  hours per response ....... 0.5
                                                  ------------------------------

              UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 3

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

                         (PRINT OR TYPE RESPONSES)


================================================================================
1. Name and Address of Reporting Person

     Menkes               Alan                     B.
- --------------------------------------------------------------------------------
   (Last)               (First)                 (Middle)


     c/o Thomas Weisel Partners Group LLC

     One Montgomery Street, Suite 3700
- --------------------------------------------------------------------------------
                                    (Street)

     San Francisco       California               94101
- --------------------------------------------------------------------------------
   (City)               (State)                 (Zip)


================================================================================
2. Date of Event Requiring Statement (Month/Day/Year)

     2/23/00

================================================================================
3. IRS or Identification Number of Reporting Person, if an entity (Voluntary)


================================================================================
4. Issuer Name AND Ticker or Trading Symbol

     Optika Inc. (OPTK)
================================================================================
5 Relationship of Reporting Person(s) to Issuer
   (Check all applicable)

   [ X ]   Director                             [   ]   10% Owner
   [   ]   Officer (give title below)           [   ]   Other (specify below)




================================================================================
6. If Amendment, Date of Original (Month/Day/Year)


================================================================================
7. Individual or Joint/Group Filing
     (Check Applicable Line)

   [ X ]   Form Filed by One Reporting Person
   [   ]   Form Filed by More than One Reporting Person

================================================================================
<TABLE>
<CAPTION>

             Table I -- Non-Derivative Securities Beneficially Owned
================================================================================

                                                                 3. Ownership Form:
                                      2. Amount of Securities       Direct (D) or
1. Title of Security                     Beneficially Owned         Indirect (I)       4. Nature of Indirect Beneficial Ownership
   (Instr. 4)                            (Instr. 4)                 (Instr. 5)            (Instr.5)
- ------------------------------------------------------------------------------------------------------------------------------------
   <S>                                   <C>                         <C>                  <C>


- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.

*  If the form is filed by more than one reporting person,
   see Instruction 5(b)(v).

POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED
IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY
VALID OMB CONTROL NUMBER.

<PAGE>


FORM 3 (continued)

<TABLE>
<CAPTION>

              TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED
         (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)

================================================================================
                                                                                                        5. Owner-
                                                    3. Title and Amount of Securities                      ship
                                                       Underlying Derivative Security                      Form of
                         2. Date Exercisable           (Instr. 4)                                          Derivative
                            and Expiration Date     ---------------------------------    4. Conver-        Security:
                            (Month/Day/Year)                               Amount           sion or        Direct      6. Nature of
                         ----------------------                            or               Exercise       (D) or         Indirect
1. Title of Derivative   Date       Expira-                                Number           Price of       Indirect       Beneficial
   Security              Exer-      tion                                   of               Derivative     (I)            Ownership
   (Instr. 4)            cisable    Date            Title                  Shares           Security       (Instr.5)      (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S>                      <C>        <C>             <C>                    <C>           <C>            <C>            <C>

Series A Convertible                              Common Stock, par
Preferred Stock, par                              value $0.001 per
value $0.001 per share   Immed.   2/23/2008       share                    (1)           $20.496        (3)            (3)
- ------------------------------------------------------------------------------------------------------------------------------------
                                                  Common Stock, par
Warrants to purchase                              value $0.001 per
Common Stock             Immed.   2/23/2008       share                    (2)           $22.448        (3)            (3)
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================
</TABLE>
Explanation of Responses:

SEE ATTACHED.


/s/ Alan B. Menkes                                             March 3, 2000
- ---------------------------------------------            -----------------------
      (**)Signature of Reporting Person                           Date

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations.  See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:     File three copies of this Form, one of which must be manually signed.
          If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.

<PAGE>



                                     FORM 3
                                     ------

                               CONTINUATION SHEET

Item 1:  Alan B. Menkes
         c/o Thomas Weisel Partners Group LLC
         One Montgomery Street, Suite 3700
         San Francisco, CA  94101

Item 2:  February 23, 2000

Item 4:  Optika Inc. (OPTK)

- --------------------------------

EXPLANATION OF RESPONSES:

(1)  Each share of Series A Convertible Preferred Stock, par value $0.001
     ("Preferred Stock") is convertible into the number of shares of Common
     Stock, par value $0.001 ("Common Stock"), obtained by dividing the
     liquidation preference at the time of conversion by the conversion
     price then in effect of such share of Preferred Stock. The liquidation
     preference of each share of Preferred Stock is $20.496 plus an amount
     equal to dividends thereon which are deemed to cumulate and accrue
     from the date of issuance of such share at a rate of 8% per annum,
     compounded semi-annually through the eighth anniversary of issuance,
     at which time the Preferred Stock is subject to mandatory redemption.
     The initial conversion price of each share of Preferred Stock is
     $20.496, subject to adjustment for customary antidilution events.
     Based on the initial conversion price and assuming the shares of
     Preferred Stock remain outstanding until the eighth anniversary of
     issuance and are not earlier converted or redeemed, the 695,258 shares
     of Preferred Stock would be convertible into an aggregate of 1,302,205
     shares of Common Stock. Based on the initial conversion price, as of
     the date of issuance the 695,258 shares of Preferred Stock are
     convertible into an aggregate of 695,258 shares of Common Stock.

(2)  The warrants to purchase up to an aggregate of 291,933 shares of
     Common Stock may be exercised at any time in whole and, from time to
     time, in part until February 23, 2008, at an exercise price of
     $22.448, subject to adjustment for customary antidilution events.

(3)  The Reporting Person is an executive committee member of the Thomas
     Weisel Partners Group LLC ("TWPG"). TWPG may be deemed to own
     beneficially and indirectly in the aggregate the securities reported
     herein through certain investment limited partnerships (the "Limited
     Partnerships") of which a wholly owned affiliate of TWPG is the
     general partner. The securities reported herein are owned directly by
     the Limited Partnerships. The Reporting Person disclaims beneficial
     ownership of the securities reported herein, except to the extent of
     his pecuniary interest therein, if any.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission